These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A comparative trial of controlled-onset, extended-release verapamil, enalapril, and losartan on blood pressure and heart rate changes. Bakris G, Sica D, Ram V, Fagan T, Vaitkus PT, Anders RJ. Am J Hypertens; 2002 Jan; 15(1 Pt 1):53-7. PubMed ID: 11824861 [Abstract] [Full Text] [Related]
6. Enalapril in essential hypertension. Herrera-Acosta J, Pérez-Grovas H, Fernández M, Arriaga J. Drugs; 1985 Jan; 30 Suppl 1():35-46. PubMed ID: 2994986 [Abstract] [Full Text] [Related]
7. Lipid profile during antihypertensive treatment. The SLIP Study Group. Study on Lipids with Isoptin Press. Libretti A, Catalano M. Drugs; 1993 Jan; 46 Suppl 2():16-23. PubMed ID: 7512469 [Abstract] [Full Text] [Related]
8. Enalapril in treatment of hypertension with renal artery stenosis. Changes in blood pressure, renin, angiotensin I and II, renal function, and body composition. Hodsman GP, Brown JJ, Cumming AM, Davies DL, East BW, Lever AF, Morton JJ, Murray GD, Robertson JI. Am J Med; 1984 Aug 20; 77(2A):52-60. PubMed ID: 6089557 [Abstract] [Full Text] [Related]
9. Natriuretic effect and changes in renal haemodynamics induced by enalapril in essential hypertension. Sánchez RA, Marcó E, Gilbert HB, Raffaele P, Brito M, Giménez M, Moledo LI. Drugs; 1985 Aug 20; 30 Suppl 1():49-58. PubMed ID: 2994987 [Abstract] [Full Text] [Related]
15. Enalapril versus triple-drug therapy in the treatment of renovascular hypertension. Reams GP, Bauer JH. Drugs; 1985 Aug 20; 30 Suppl 1():59-69. PubMed ID: 2994988 [Abstract] [Full Text] [Related]
16. Effect of inhibition of converting enzyme on renal hemodynamics and sodium management in polycystic kidney disease. Torres VE, Wilson DM, Burnett JC, Johnson CM, Offord KP. Mayo Clin Proc; 1991 Oct 20; 66(10):1010-7. PubMed ID: 1921483 [Abstract] [Full Text] [Related]
17. Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state. Cleland JG, Dargie HJ, Ball SG, Gillen G, Hodsman GP, Morton JJ, East BW, Robertson I, Ford I, Robertson JI. Br Heart J; 1985 Sep 20; 54(3):305-12. PubMed ID: 2994698 [Abstract] [Full Text] [Related]
18. Comparison of enalapril and propranolol in essential hypertension. van Schaik BA, Geyskes GG, Kettner N, Boer P, Mees EJ. Eur J Clin Pharmacol; 1986 Sep 20; 29(5):511-6. PubMed ID: 3007162 [Abstract] [Full Text] [Related]
19. Aldosterone response to antihypertensive treatment. de Leeuw PW, van Soest GA, Birkenhäger WH. Clin Exp Hypertens A; 1982 Sep 20; 4(9-10):1913-21. PubMed ID: 6291819 [Abstract] [Full Text] [Related]
20. Double-blind comparison of captopril and enalapril in mild to moderate hypertension. Vlasses PH, Conner DP, Rotmensch HH, Fruncillo RJ, Danzeisen JR, Shepley KJ, Ferguson RK. J Am Coll Cardiol; 1986 Mar 20; 7(3):651-60. PubMed ID: 3005384 [Abstract] [Full Text] [Related] Page: [Next] [New Search]